Revvity (RVTY) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
16 Mar, 2026Executive summary
Annual meeting scheduled for April 28, 2026, with voting available online and virtually.
Shareholders are encouraged to review proxy materials and vote on key proposals by specified deadlines.
Voting matters and shareholder proposals
Election of ten director nominees for one-year terms is up for vote.
Ratification of Deloitte & Touche LLP as independent auditor for the current fiscal year.
Advisory vote on executive compensation (say-on-pay) is included.
Proposal to amend by-laws to allow shareholders with 25% ownership to call a special meeting.
Shareholder proposal requiring executives to retain significant stock is presented, with board recommending against.
Board of directors and corporate governance
Ten nominees for director positions are listed, each recommended for election for a one-year term.
Board recommends voting for all director nominees.
Latest events from Revvity
- Targeting 6%-8% organic growth and margin expansion through innovation and operational synergies.RVTY
Investor Day 20248 Jul 2026 - Life sciences and software growth accelerate as pharma biotech recovers and AI adoption expands.RVTY
Citi Annual Global Healthcare Conference 20258 Jul 2026 - Q3 revenue up 2% to $684M, adjusted EPS $1.28, and new $1B share repurchase program.RVTY
Q3 20248 Jul 2026 - Strong growth, portfolio optimization, and innovation drive optimism for sustained margin expansion.RVTY
Goldman Sachs 47th Annual Global Healthcare Conference 20269 Jun 2026 - Divestiture of China immunodiagnostics boosts growth outlook; AI and software launches drive optimism.RVTY
Bank of America Global Healthcare Conference 202613 May 2026 - Q1 2026 revenue up 7%, strong organic growth, and China divestiture shapes 2026 outlook.RVTY
Q1 202612 May 2026 - Board elections, auditor ratification, and bylaw changes passed; stock retention proposal failed.RVTY
AGM 202628 Apr 2026 - Board recommends all management proposals, including by-law amendment, and opposes stock retention proposal.RVTY
Proxy Filing16 Mar 2026 - AI-powered Signals launches and new revenue models drive growth amid cautious market outlook.RVTY
Barclays 28th Annual Global Healthcare Conference10 Mar 2026